Clinical Trial Update: Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating selenomethionine in patients undergoing surgery or internal radiation therapy for Stage I-II prostate cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Selenomethionine (selenomethionine)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: WITHDRAWN